GSK and Oxford Collaborate to Pave the Way for Life-Saving Cancer Vaccines

A second research collaboration between SK and the University of Oxford allows analysis of cancer prevention through vaccine therapy. The GSK-Oxford immuno-anticipation program will conduct translational research by studying precancer science to better understand human cancer evolution which creates potential opportunities for new vaccines. Early research follows GSK’s commitment of up to £50m ($62.3m) across three years. Oxford University’s expertise […]